English 
Japanese 
December 26, 2024
Announcement of Appointment and Resignation of Directors
We are pleased to announce that at our Ordinary General Meeting of Shareholders held on December...
Read More
December 16, 2024
Our CEO Takahara Featured on “IRTV” Video Media
Our CEO, Takahara, recently appeared on IRTV, a video platform connecting investors and companies. YouTube: IRTV...
Read More
December 16, 2024
Event Report: CTO Toma Speaks at LINK-J and Merck Co-hosted Symposium
On Wednesday, November 13, 2024, our CTO, Toma, delivered a presentation at the symposium titled "Chemistry...
Read More
October 23, 2024
CEO Featured on Radio NIKKEI
We’re excited to share that our CEO, Takehara, was featured on Radio NIKKEI’s program, Leaders in...
Read More
October 7, 2024
Selected as a Finalist for the CITELINE Japan Award 2024 Biotech Company of the Year
We are honored to announce that we’ve been chosen as a finalist for the prestigious Biotech...
Read More
September 30, 2024
Notice of Article Published in the Nikkei
Prism BioLab in the Spotlight for Drug Discovery, Recognized by Major Pharma www.nikkei.com/article/DGXZQOUC06CAK0W4A900C2000000/
Read More
September 9, 2024
Eisai to Present E7386, co-created by PRISM BioLab and Eisai, at the ESMO (European Society for Medical Oncology) Annual Meeting
TOKYO, Japan, 9 September 2024: -- PRISM BioLab, Co. Ltd. , a leading discovery and development...
Read More
September 2, 2024
PRISM BioLab opens a business office in Tokyo
We are pleased to announce the establishment of PRISM BioLab Co., Ltd. Tokyo office. The office...
Read More
July 2, 2024
Announcement of Initial Listing on Tokyo Stock Exchange Growth Market
PRISM BioLab Corporation is pleased to announce its initial listing on the Tokyo Stock Exchange Growth...
Read More
May 27, 2024
Notice of Approval for Listing on the Growth Market of the Tokyo Stock Exchange
PRISM BioLab is pleased to announce that the Tokyo Stock Exchange today approved the initial listing...
Read More